AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Visionary Holdings Inc., a technology-driven multinational enterprise listed on Nasdaq, has launched its medical-grade stem cell anti-aging product line, targeting the Chinese mainland and broader Asian markets. The product portfolio includes three major categories: Comprehensive Regenerative Package, combining mesenchymal stem cells, NK cell therapy, and AI-based diagnostic. This launch marks a major milestone following GV's entry into the stem cell and medical aesthetics sector earlier this year.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet